OpenAlex
PricingAboutJobs
Log inGet started
Work

Is a reduction in albuminuria associated with renal and cardiovascular protection? A post hoc analysis of the ALTITUDE trial

HTML

Year: 2016
Type: article
Source: Diabetes Obesity and Metabolism
DOI: 10.1111/dom.12600
Authors: H. J. L. Heerspink, T. Ninomiya, F. Persson, B. M. Brenner, P. Brunel, N. Chaturvedi, A. S. Desai, S. M. Haffner, J. J. V. Mcmurray, S. D. Solomon, M. A. Pfeffer, H.‐H. Parving, D. de Zeeuw
Institutions: University Medical Center Groningen, University of Groningen, Kyushu University, Brigham and Women's Hospital, Harvard University, Novartis (Switzerland), University College London, The University of Texas at San Antonio Health Science Center, British Heart Foundation, University of Glasgow, University of Copenhagen, Rigshospitalet
Language: English

Topic: Chronic Kidney Disease and Diabetes
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Keywords: albuminuria, aliskiren, type 2 diabetes, chronic kidney disease, cardiovascular disease, renal protection, cardioprotection, ACE inhibitors, angiotensin receptor blockers, renin-angiotensin system
SDG: Good health and well-being

Open Access status: closed

Funder: Novartis Pharmaceuticals Corporation
OpenAlex ID: W1945685354
FWCI: 6.947
Cites: 34
Cited by: 64
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security